Blume Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,000
| Closed | – | – | 236 |
|
|
2020
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 248 |
|
|
2020
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 198 |
|
|
2019
Q4 | $23K | Hold |
1,000
| – | – | 0.01% | 156 |
|
|
2019
Q3 | $26K | Hold |
1,000
| – | – | 0.01% | 153 |
|
|
2019
Q2 | $27K | Hold |
1,000
| – | – | 0.01% | 144 |
|
|
2019
Q1 | $35K | Hold |
1,000
| – | – | 0.02% | 143 |
|
|
2018
Q4 | $20K | Hold |
1,000
| – | – | 0.01% | 162 |
|
|
2018
Q3 | $27K | Hold |
1,000
| – | – | 0.01% | 140 |
|
|
2018
Q2 | $38K | Hold |
1,000
| – | – | 0.02% | 126 |
|
|
2018
Q1 | $32K | Hold |
1,000
| – | – | 0.02% | 140 |
|
|
2017
Q4 | $49K | Hold |
1,000
| – | – | 0.03% | 123 |
|
|
2017
Q3 | $54K | Hold |
1,000
| – | – | 0.03% | 116 |
|
|
2017
Q2 | $56K | Hold |
1,000
| – | – | 0.03% | 97 |
|
|
2017
Q1 | $39K | Hold |
1,000
| – | – | 0.02% | 114 |
|
|
2016
Q4 | $22K | Hold |
1,000
| – | – | 0.01% | 134 |
|
|
2016
Q3 | $23K | Hold |
1,000
| – | – | 0.01% | 124 |
|
|
2016
Q2 | $24K | Hold |
1,000
| – | – | 0.02% | 135 |
|
|
2016
Q1 | $20K | Hold |
1,000
| – | – | 0.01% | 145 |
|
|
2015
Q4 | $51K | Hold |
1,000
| – | – | 0.04% | 101 |
|
|
2015
Q3 | $43K | Hold |
1,000
| – | – | 0.03% | 105 |
|
|
2015
Q2 | $46K | Hold |
1,000
| – | – | 0.03% | 117 |
|
|
2015
Q1 | $38K | Hold |
1,000
| – | – | 0.03% | 149 |
|
|
2014
Q4 | $28K | Hold |
1,000
| – | – | 0.02% | 177 |
|
|
2014
Q3 | $25K | Hold |
1,000
| – | – | 0.02% | 129 |
|
|
2014
Q2 | $29K | Hold |
1,000
| – | – | 0.02% | 126 |
|
|
2014
Q1 | $26K | Hold |
1,000
| – | – | 0.02% | 143 |
|
|
2013
Q4 | $26K | Buy |
+1,000
| New | +$26K | 0.02% | 162 |
|